Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2α in cutaneous melanoma

British Journal of Cancer

Volumn 82, Issue 12, 2000, Pages 2015-2021

  Karjalainen, J M ^a,c   Kellokoski, J K ^a   Mannermaa, A J ^a   Kujala, H E ^a   Moisio, K I ^a   Mitchell, P J ^b   Eskelinen, M J ^a   Alhava, E M ^a   Kosma, V M ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

AP 2; Cutaneous melanoma; Gene expression; Loss of heterozygosity; MRNA in situ hybridization

Indexed keywords

MESSENGER RNA; MICROSATELLITE DNA; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CHROMOSOME 6; CLINICAL TRIAL; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; MONOSOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA TRANSCRIPTION; TUMOR SUPPRESSOR GENE;

DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MELANOMA; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0034126455     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, van Tuinen P, Ledbetter DH, Barker DF and Nakamura Y (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221
2. Bar-Eli M (1997) Molecular mechanisms or melanoma metastasis. J Cell Physiol 173: 275-278
3. Bosher JM, Williams T and Hurst HC (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92: 744-747
4. Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW and Tainsky MA (1993) An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 13: 4174-4185
5. WAF1/CIP1/SDU mRNA and protein expression upon genotoxic stress. Oncogene 17: 781-787
6. Canzian F, Salovaara R, Hemminki A, Cristo P, Chadwich RB, Aaltonen LA and dela-Chapelle A (1996) Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56: 3331-3337
7. Day DA and Tuite MF (1998) Post-transcriptional gene regulatory mechanisms in eukaryocytes: an overview. J Endocrinol 157: 361-371
8. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KL, Jenkins RB and Benedict WF (1994) Evidence of functional RB protein in epithelial ovarian carcinomas despite the loss of heterozygosity at RB locus. Cancer Res 54: 610-613
9. Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ and Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67: 551-559
10. Gaynor RB, Muchard C, Xia Y, Klisak I, Mohandas T, Sparkes RS and Lusis AJ (1991) Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 10: 1100-1102
11. Gonzalgo ML, Bender CM, You EH, Glendening JM, Flores JF, Walker GJ, Hayward NK, Jones PA and Fountain JW (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res 57: 5336-5347
12. Huang S, Jean D, Luca M, Tainsky MA and Bar-Eli M (1998) Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17: 4358-4369
13. Imhof A, Schuierer M, Werner O, Moser M, Roth C, Bauer R and Buettner R (1999) Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zine finger repressor. Mol Cell Biol 19: 194-204
14. Isola J, De Vries S, Chu L, Chazni S and Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 115: 1301-1308
15. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA and Bar-Eli M (1998) Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 273: 16501-16508
16. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM and Kosma VM (1998) Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol 16: 3584-3591
17. Kleijn M, Scheper GC, Voorma HO and Thomas AAM (1998) Regulation of translation initiation factors by signal transduction. Eur J Biochem 253: 531-544
18. Knudson AGJ (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
19. Levine AJ and Momand J (1990) Tumor suppressor genes: the p53 and retinioblastoma sensitivity genes and gene products. Biochimica Biophysica Acta 1032: 119-136
20. Liu SY and Redmond TM (1998) Role of the 3′-untranslated region of RPE65 mRMA in the translational regulation of the RPE65 gene: identification of a specific translation inhibitory element. Arch Biochem Biophys 357: 37-44
21. Meier P, Koedood M, Philipp J, Fontana A and Mitchell PJ (1995) Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis. Dev Biol 169: 1-14
22. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51: 5449-5453
23. Mitchell PJ, Wang C and Tjian R (1987) Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50: 847-861
24. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW and Tjian R (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 5: 105-119
25. Noviello C, Courjal F and Theillet C (1996) Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Clin Cancer Res 2: 1601-1606
26. Ohtaka-Maruyama C, Hanaoka F and Chepelinsky AB (1998) A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens. Dev Biol 202: 125-135
27. Real LM, Jimenez P, Canton J, Kirkin A, Garcia A, Abril E, Zeuthen J, Ruiz-Cabello F and Garrido F (1998) In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele. Int J Cancer 75: 317-323
28. Robertson GP, Coleman AB and Lugo TG (1996) Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res 56: 1635-1641
29. Sellers WR and Kaelin WGJ (1997) Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 15: 3301-3312
30. Slominski A, Wortsman J, Nickoloff B, McClatchey K, Mihm MC and Ross JS (1998) Molecular pathology of malignant melanoma. Am J Clin Pathol 110: 788-794
31. Sugg SL, Ezzat S, Rosen IB, Freeman JL and Asa SL (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metabol 83: 4116-4122
32. Trent JM, Stanbridge EJ, MeBride HL, Meese EU, Casey G, Araujo D, Witkowski CM and Nagle RB (1990) Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568-571
33. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG and Williams T (1998) Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58: 5466-5472
34. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PG and Hayward NK (1994) Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma. Int J Cancer 58: 203-206
35. Wang E, Ma W-J, Aghajanian C and Spriggs DR (1997) Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3′-untranslated region of tumor necrosis factor-α messenger RNA. Cancer Res 57: 5426-5433
36. Williamson JA, Bosher JM, Skinner A, Sheer D, Williams T and Hurst HC (1996) Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 35: 262-264
37. Zeng YX, Somasundaram K and el-Deiry WS (1997) AP2 inhibits cancer cell growth and activates p21 WAF1/CIP1 expression. Nat Genet 15: 78-82